Hostname: page-component-74656f9884-8rzl6 Total loading time: 0 Render date: 2026-11-05T22:39:44.097Z Has data issue: false hasContentIssue false

A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?

Published online by Cambridge University Press:  01 December 2015

Juliana Francisco Cecato
Affiliation:
Department of Internal Medicine, Faculty of Medicine of Jundiaí, State of São Paulo, Brazil
José Eduardo Martinelli
Affiliation:
Department of Internal Medicine, Faculty of Medicine of Jundiaí, State of São Paulo, Brazil
Rafael Izbicki
Affiliation:
Department of Statistics, Federal University of São Carlos (UFSCar), State of São Paulo, Brazil
Mônica Sanches Yassuda
Affiliation:
Department of Neurology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, Brazil
Ivan Aprahamian*
Affiliation:
Department of Internal Medicine, Faculty of Medicine of Jundiaí, State of São Paulo, Brazil Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
*
Correspondence should be addressed to: Ivan Aprahamian, MD, MS, PhD, FACP, Department of Internal Medicine, Faculty of Medicine of Jundiaí. Rua Francisco Telles, 250, Vila Arens, Jundiaí, São Paulo, ZIP: 13202-550, Brazil. Phone: 55-11 4587-1095. Email: ivan.aprahamian@gmail.com.

Abstract

Background:

It is necessary to continue to explore the psychometric characteristics of key cognitive screening tests such as the Montreal Cognitive Assessment (MoCA) to diagnose cognitive decline as early as possible and to attend to the growing need of clinical trials involving mild cognitive impairment (MCI) participants. The main aim of this study was to assess which MoCA subtests could best discriminate between healthy controls (HC), participants with MCI, and Alzheimer's disease (AD).

Methods:

Cross-sectional analysis of 136 elderly with more than four years of education. All participants were submitted to detailed clinical, laboratory, and neuroimaging evaluation. The MoCA, Mini-Mental State Examination (MMSE), the Cambridge Cognitive Examination (CAMCOG), Geriatric Depression Scale (GDS), and Functional Activities Questionnaire (FAQ) were applied to all participants. The MoCA test was not used in the diagnostic procedure.

Results:

Median MoCA total scores were 27, 23 and 18 for HC, MCI, and AD, respectively (p < 0.001). Word repetition, inverse digits, serial 7, phrases, verbal fluency, abstraction, and word recall discriminated between MCI and HC participants (p < 0.001). The clock drawing, the rhino naming, delayed recall of five words and orientation discriminated between patients with MCI and AD (p < 0.001). A reduced version of the MoCA with only these items did not improve accuracy between MCI and HC (p = 0.076) or MCI and AD (p = 0.119).

Conclusions:

Not all MoCA subtests might be fundamental to clinical diagnosis of MCI. The reduced versions of MoCA did not add diagnostic accuracy.

Information

Type
Research Article
Copyright
Copyright © International Psychogeriatric Association 2015 
Figure 0

Table 1. Characteristics of the sample regarding age, sex, and education

Figure 1

Table 2. Median and inter-quartile scores for the MMSE, CAMCOG, GDS, FAQ of the three groups

Figure 2

Table 3. Total and subtest MoCA scores for the three diagnostic groups: median, inter-quartile interval, and percentages of correct answers

Figure 3

Table 4. Receiver operating characteristic curves area, cut-off, sensitivity, specificity, and accuracy for the FAQ, MoCA, and MoCA reduced to differentiate between MCI and AD groups

Figure 4

Table 5. Receiver operating characteristic curves area, cut-off, sensitivity, specificity, and accuracy for the MoCA and MoCA reduced to differentiate between MCI and HC groups